ExThera Medical
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
757 Arnold Dr Ste B, Martinez, Californi...Phone Number
(925) 839-2060Website
www.extheramedical.comRevenue
$6.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About ExThera Medical
ExThera Medical Corporation develops and commercializes extracorporeal blood filtration devices, including the Seraph® 100 Microbind® Affinity Blood Filter for removing a broad range of pathogens from the bloodstream of patients. Seraph can be used in hospitals, clinics, or field hospitals to address nosocomial and community-acquired infections as well as those caused by battlefield wounds and pandemics. ExThera Medical's extracorporeal products have demonstrated life-saving capabilities in a wide range of critically ill patients suffering from sepsis and other severe infections. With a growing body of outcome and health economic evidence from independent clinical studies, success in the DARPA Dialysis-Like Therapeutics program, and from successful clinical use in the US, the EU, and the Middle East, the company is well positioned to serve healthcare professionals and patients alike. The Seraph® 100 is CE marked and commercially available in the EU. The Seraph® 100 has FDA Emergency UsRead more
ExThera Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ExThera Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ExThera Medical recently announced quarterly report
Click to see if ExThera Medical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ExThera Medical has new funding data
Check out if ExThera Medical is spiking on competitors!
Product Launch: Get notified when ExThera Medical launches new products
Congratulate Masked Content for being promoted to Masked Content at ExThera Medical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if ExThera Medical has recently received funding, and reach out quickly before it becomes old news!
ExThera Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined ExThera Medical as Masked Content
Find more new buyers
Compare Similar Companies to ExThera Medical
Compare insights from companies similar to ExThera Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ExThera Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ExThera Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ExThera Medical.
ExThera Medical financials insights
Gather financial insights about ExThera Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$12M
2014
Angel/Seed
$3.8M
2016
Series B
$15.3M
2020
Debt
$350K
ExThera Medical Tech Stack
A closer look at the technologies used by ExThera Medical
Most Recent Scoops
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
ExThera Medical News & Media
ExThera Medical Announces Resolution of Federal Investigation
ExThera Has Reached a Resolution with the U.S. Department of Justice, with Substantial Recognition for Cooperating in the Investigation and Implementing Remedial Measures MARTINEZ, Calif., March 5, 2026 /PRNewswire/ -- ExThera Medical has resolved a United States Department of Justice...ExThera Medical's Blood Filtration Device Shows Promise for Sepsis Patients After Cardiac Surgery
MARTINEZ, Calif.--(BUSINESS WIRE)--A newly published study in Nature’s Scientific Reports finds that use of ExThera’s Seraph® 100 blood filter in septic patients following cardiac surgery significantly improved outcomes by rapidly reducing pathogen load in the bloodstream. Sepsis—a life-threatening condition caused by the body’s extreme response to infection—can lead to organ failure and death if not treated quickly. Patients undergoing surgery for infective endocarditis (IE), a serious infectiCORRECTING and REPLACING ExThera Medical Receives MTEC Award for Pivotal Sepsis Trial
MARTINEZ, Calif.--(BUSINESS WIRE)--Please replace the release dated Jan. 22, 2025 with the following corrected version due to multiple revisions. The updated release reads: EXTHERA MEDICAL RECEIVES MTEC AWARD FOR PIVOTAL SEPSIS TRIAL Randomized trial at LSU Health Shreveport will evaluate Seraph 100 Blood Filter's effectiveness in treating sepsis caused by wound infections. ExThera Medical announced that it has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) toSeraph 100 Blood Filtration Media May Reduce Tumor-Associated Particles in Blood Samples Drawn From Pancreatic Cancer Patients
MARTINEZ, Calif.--(BUSINESS WIRE)--A new laboratory study has provided insights into the potential therapeutic benefits of blood purification for patients with metastatic pancreatic ductal adenocarcinoma (PDAC), one of the deadliest forms of cancer. Researchers have demonstrated that ExThera Medical’s Seraph® 100 Microbind ® Affinity Blood Filter (Seraph 100) adsorption media selectively removes specific tumor-associated microparticles from the blood of PDAC patients, offering the potential for
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ExThera Medical
Sign Up For FreeTo access detailed company insights
ExThera Medical Corporation develops and commercializes extracorporeal blood filtration devices, including the Seraph® 100 Microbind® Affinity Blood Filter for removing a broad range of pathogens from the bloodstream of patients. Seraph can be used in hospitals, clinics, or field hospitals to address nosocomial and community-acquired infections as... Read More
